T2 Translational Research: Research Leading to New Health Care Practices, Community Programs and Policies Affecting Older Persons (R21)
This funding opportunity announcement (FOA) encourages exploratory/developmental research projects on translational research (T2) directed towards development of health care practices, community programs and policies, including monitoring and quality improvement for pharmacological and non-pharmacological approaches for preventing and treating key health issues affecting the elderly. For the purposes of this FOA, T2 translational research on aging is defined as research to gather information needed to develop or evaluate methods of translating results from clinical studies into everyday clinical practice and health decision making (e.g., adapting an efficacious intervention for application in clinical practice and evaluating its effectiveness in different clinical settings). Methods for T2 translational research include but are not limited to intervention studies, systematic reviews, meta-analysis, outcomes research and implementation research.
Novel interventions without known efficacy for prevention and treatment of age-related conditions should refer to the companion FOA for T1 research PAR-18-177, R21Exploratory/Developmental Research Grant.
- R21 Deadlines: Feb. 16, Jun. 16, Oct. 16
- AIDS Deadlines: Jan. 7, May 7, Sep. 7
PAR-18-178 Expiration Date September 8, 2018
Direct costs are limited to $275,000 over an R21 two-year period, with no more than $200,000 in direct costs allowed in any single year.